Five products, five prices, no intake
The compounded semaglutide and tirzepatide vials each have a product page with a figure on it. So do Ozempic, Wegovy and Zepbound, at figures more than ten times higher.
Each page also states the physical form — a multi-dose vial for the compounded products, a single-patient-use pen for the branded ones. That distinction explains a great deal about the price gap and almost nobody else on this roster mentions it.
Its Ozempic page carries an unusually careful sentence: that the weight-loss effects of that drug are not FDA-approved and should therefore not be promoted. A seller writing that on its own product page is doing something most do not.
The deadline inside the price
A banner runs across every page advertising the two compounded figures and naming a date and a time at which the offer ends.
That makes them promotional rates, not standing ones. We record them with the deadline quoted in the price record itself, because a figure with an expiry in it stops being true on a date this seller has already published.
The banner also promises the same price every month, which is a different claim from a countdown, and both appear in the same sentence.
A membership nobody has priced
Every product page describes prescribing as happening through the company's healthcare membership. No page we read says what that membership costs, or whether its cost is already inside the advertised figure.
So the advertised number may be the whole bill or a part of it, and the site does not resolve it.
What this host does to a test
A deliberately nonsensical address on this domain does not return an error. It returns a success and lands the reader on a marketing offer page.
That means nothing about this seller can be recorded as absent because an address failed. Everything above is read from text visible on a page that really exists.
Two smaller things are worth naming. Every one of the five product pages carries the same rating and the same review count, so that figure describes the site rather than the product. And the privacy contact block gives an address in Sweden beside a United States one.
It carries an FDA warning letter issued in June 2026 over false and misleading claims and misbranding, addressed to the company the site itself names as the operator. That is a disclosure and it does not move this seller's position here.
altRx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $89/mo⛔ A DATED PROMOTIONAL RATE, AND THE DATE IS IN THE BANNER: "Save Big this SUMMER. SAME PRICE EVERY MONTH! STARTING at GLP-1: $89 | GLP-1 + GIP: $149. OFFER ENDS SEPTEMBER 10TH AT MIDNIGHT!" The product page prints "$89/mo" beside "Rx only + Multi-dose vial" and the site elsewhere names the molecule as Compounded Semaglutide | September 2026source |
| Tirzepatide (compounded) | $149/mo⛔ THE SAME DATED PROMOTION governs this figure; the product page prints "$149/mo" beside "Rx only + Multi-dose vial" on a product titled Compounded GLP-1 / GIP, which the site names elsewhere as Compounded Tirzepatide | September 2026source |
| Semaglutide (brand) | $1,149/moper month for the branded product, printed on its own product page as "$1149/mo" beside "Rx only + Single-patient-use pen" | September 2026source |
| Semaglutide (brand) | $1,579/moper month for the branded product — "$1579/mo", the highest single figure this seller publishes | September 2026source |
| Tirzepatide (brand) | $1,249/moper month for the branded product — "$1249/mo" beside "Rx only + Single-patient-use pen" | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 264 providers reviewed here are paid partners today; the other 260 are not. See how this works.
See altRx's current price →Good fit if
- Buyers who want to see a compounded vial and a branded pen priced on the same site.
- Readers who care whether they are buying a vial or a pen.
- People acting before the deadline the banner names.
Look elsewhere if
- Anyone who needs a standing rate rather than a countdown offer.
- Buyers who need to know what the membership costs.
- Readers who need the compounding pharmacy or the prescriber named.
- People who need their state confirmed before starting.
How this review was verified
- Read the homepage, the privacy policy and all five product pages on 7 September 2026, comparing requested to effective URLs, with a nonsense path on the same host in the same run — it returned a 200 and a marketing page, so no absence is claimed in this review.
- Took each figure from its own product page rather than from the site-wide banner, and recorded the banner's deadline in each price record.
- Reached the five product pages through links on the site's own homepage rather than by guessing addresses, which matters on a host that succeeds for addresses that do not exist.
- Recorded the membership as named-but-unpriced rather than assuming the advertised figure includes it.
- Screened the live FDA warning-letter datatable by the operating company's name with a positive control returning exactly one row and a nonsense control returning none.